Biosynthesis of valinomycin  by Ristow, H. et al.
Volume 42, number 2 FEBS LETTERS June 1974 
BIOSYNTHESIS OF VALINOMYCIN 
H. RISTOW, J. SALNIKOW and H. KLEINKAUF 
Institut fiir Biochemie, Technische Universitdt Berlin, 
1 Berlin 10, Franklinstrafle 29, Germany 
Received 29 March 1974 
1. Introduction 
Valinomycin is a cyclododecadepsipeptide consis- 
ting of three residues each of L-valine, ~-D-hydroxy- 
isovaleric acid, D-valine and L-lactic acid joined to- 
gether by alternating amide and ester linkages [1 ]. 
The results on the biosynthesis of gramicidin S [2], 
tyrocidine [3] and alamethicin [4] suggest hat 
valinomycin is formed by a similar non-ribosomal pep- 
tide synthesizing mechanism. In this report we des- 
cribe the isolation of an enzyme complex that is ca- 
pable of synthesizing the complete molecule of valino- 
mycin from the precursors L-valine and L-alanine or 
L-threonine. 
2. Materials and methods 
2.1. Growth of  the organism and identification of  
[ 14 C] valinomycin 
A valinomycin producing strain of Streptomyces 
fulvissimus was grown at 37°C with vigorous tirring 
and aeration in 101 of medium containing 200 g soy 
bean peptone (Merck) and 100 g yeast extract (Merck). 
When the optical density at 600 nm was 1.5, the cells 
(about 15 g) were harvested at room temperature, and 
reincubated in 101 synthetic medium (200 g sodium 
glutamate, 100 g glucose, 10 g KH2PO4, and 25 mg 
each of FeSO4 • 7 H20, CaC12, MgSO4 • 7 H20, and 
ZnSO4 - 7 H20) for 1 hr. The cells were collected by 
centrifugation a d kept frozen at -90°C. 
For in vivo experiments 20 ml of cell suspension 
(optical density .= 1.5) were centrifuged, washed twice 
with synthetic medium and incubated overnight in 20 
mi of the same medium containing 1taCi of L - [ l  4C]. 
valine (228 mCi/mM) or of L-[a4C]alanine (128 
mCi/mM), or of L-[14C]threonine (180 mCi/mM). 
The cells were centrifuged and extracted twice with 
80% methanol. The supernatant was concentrated and 
extracted with n-butanol. The combined extracts were 
reextracted with ethyl acetate and finally chromato- 
graphed on silica thin layer plates in 50% (v/v) n- 
propanol in H20 or cyclohexane: pyridine: acetic acid 
= 100:15:5 (v/v/v) and valinomycin was detected by 
autoradiography. Authentic valinomycin as reference 
was visualized by the chlorination-iodide/starch reac- 
tion. For quantitation the radioactive valinomycin was 
eluted with ethyl acetate and the radioactivity esti- 
mated in a Nuclear Chicago Isocap scintillation coun- 
ter. Hydrolysis of the cyclic peptide was performed 
according to Brockmann et al. [ 1 ]. [14 C] Valine, 
[14C]hydroxyisovaleric acid and [14C]lactic acid 
were identified by high voltage lectrophoresis in a 
Savant apparatus on Whatman 3 MM paper at pH 1.9 
and pH 6.4, respectively. The paper strip was cut into 
segments and radioactivity was estimated in a scintilla- 
tion counter. D-Valine and L-valine were determined 
with L- and D-amino acid oxidase. Occasionally the 
peptide antibiotic was identified, in addition, by its 
ionophoretic properties in chloroplast membranes [5]. 
2.2. Enzyme preparation and purification 
Batches of cells (about 100 g) were suspended in a 
buffer containing: 0.02 M Tris-HC1, pH 7.8; 0.00025 
M EDTA; 0.01 M magnesium acetate; 0.001 M DTT, 
and 5% glycerol (buffer A) and disrupted in a glass 
bead homogenizer (B(ihler, Tiibingen) in the presence 
of 10 mg of lysozyme. The extract was treated with 
500/ag of DNAse I. Cell debris was removed by cen- 
trifugation at 10 000 g and ribosomes were pelleted at 
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100 000 g. Protein was concentrated byammonium sul- 
fate precipitation (60%). The enzyme preparation was 
passed through aSephadex G-200 column equilibrated 
with buffer A. The enzyme-containing fractions were 
located according to Gevers et al. [6] bythe ATP-PP i 
exchange reaction. Appropriate fractions were pooled 
and concentrated byammonium sulfate precipitation. 
After dialysis the enzyme fraction was loaded onto a 
DEAE column, equilibrated with buffer A. The pro- 
teins were fractionated with a 900 ml linear gradient 
of 0-0.4 M KC1 in buffer A. To demonstrate he 
formation of AMP during amino acid activation, ali- 
quots of the enzyme fraction were incubated with 0.04 
/aCi p4C]ATP (spec. act. 418 mCi/mM) in the pre- 
sence of TRA, pH 7.8 (0.025 M), magnesium acetate 
(0.01 M), EDTA (0.0025 M), DTT (0.0001 M) and 
the appropriate amino acids (0.005 M) at 37°C for 
20 min. The samples were chromatographed on PEI 
plates in 1.2 M LiCI. Radioactivity was detected with 
a Berthold Thin Layer Scanner, System BF 210. 
2.3. Synthesis of valinomycin i  vitro 
The reaction mixture contained 1ml of enzyme 
purified by DEAE-chromatography in a total volume 
of 2 ml of TRA, pH 7.8 (0.025 M), magnesium ace- 
tate (0.01 M), KC1 (0.01 M), DTT (0.0005 M), ATP 
(0.002 M), L-[~4C]val (0.001 mM = 1/aCi), L-ala 
(0.005 M), NADH (0.005 M). For ATP regeneration 
250/ag phosphoenolpyruvate kinase was added. To 
label the lactyl portion, unlabelled alanine was re. 
placed by an equivalent amount of L- [14 C ] alanine or 
L- [14 C ] threonine. When threonine was used in the 
system, NADH was replaced by NAD and pyridoxal- 
phosphate (0.005 M) as well as glutathione (0.005 M) 
were added. Occasionally the synthesis was performed 
in the presence of RNAse (50/ag/ml) or puromycin 
(20/ag/ml). The reaction mixture was incubated for 
1 hr at 37°C and valinomycin was extracted with 
butanol and ethyl ester as described above. 
3. Results 
3.1. Production of valinomycin i  Streptomyces ful- 
vissimus 
The valinomycin production in Streptomyces ful- 
vissimus was measured by short term incorporation of 
[14C] valine. It was found that the formation of vali- 
nomycin occurs only within a limited time span at the 
end of the logarithmic phase of growth. 
L-Valine forms three quarters of the valinomycin 
backbone as the precursor of both D- and L-valine, as 
well as of the D-hydroxy-iso-valeroyl moiety [7]. In- 
corporation studies with [14C] alanine identify this 
amino acid in addition as a possible precursor of the 
lactyl portion. Lactate can be formed from alanine via 
deamination and reduction. Also threonine is incor- 
porated into the lactyl portion and apparently more 
efficiently than alanine. At the moment, however, the 
mechanism by which threonine is transformed to
lactic acid is not understood. 
When valinomycin was labelled in vivo by p4C]- 
valine and [14C] alanine quantitative chemical 
analysis after acid hydrolysis howed a molar ratio of 
L-valine: D-valine: hydroxyisovaleric acid:lactic acid 
as 1.0:1.0:0.6:0.1-0.2. The low incorporation i to 
the hydroxy acids might be due to the existence of an 
internal pool as suggested by MacDonald [7]. The 
value for lactic acid might reflect incomplete recovery 
of this compound. The labelled valinomycin is active 
as an ionophore in chloroplast membranes proving its 
molecular integrity. 
3.2. Isolation of the valinomycin synthesizing enzyme 
To identify the valinomycin synthesizing enzyme 
after Sephadex G-200 filtration, the fractions were 
tested for amino acid activation by the ATP-PP i ex- 
change reaction (fig. 1). Of the constituents of vali- 
nomycin, only L-valine was activated. No activation 
of D-valine, D-hydroxyisovaleric acid, lactate or of 
L-alanine, aknown precursor of lactate, was found. A 
significant background activation without amino 
acids, however, was observed. The L-valine activating 
peak is quite broad and may contain additional activa- 
ting species uch as tRNA synthetases. Another possi- 
bility is that the broad peak reflects aggregated orde- 
graded enzyme species which are still able to activate 
L-valine. 
Within this L-valine activating peak a threonine 
activating enzyme was localized (fig. 1). This enzyme 
exhibits a remarkable high background activity. The 
fractions containing the threonine activating enzymes 
were further purified by DEAE-cellulose chromato- 
graphy. In table 1 the activation of the constituents a
well as of L-alanine and L-threonine are listed, demon- 
strating that only L-valine and - to a much smaller 
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Fig. 1. Sephadex G-200 Filtration of a ribosome free extract. 
Fractions of 4 ml were collected and aliquots of 50/zl were 
tested for L-valine- and L-threonint~-activation as well as for 
'background activation' by the ATP-PP i exchange reaction. 
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Fig. 2. Formation of AMP and ADP from [ ~4C] ATP during 
amino acid activation by the enzyme fraction after purifica- 
tion on DEAE cellulose. Samples were ehromatographed on 
PEI plates and radioactivity monitored with a Thin Layer 
Scanner. 
extent -- L-threonine are activated. The 'background 
activity' of this fraction is remarkably high, which can 
not be explained at the moment. In addition pyru- 
rate, pyruvate plus NADH, phosphoenolpyruvate nd 
propionic acid were tested for activation without po- 
sitive results. The amino acids L-phenylalanine, glycine, 
L-glutamic acid and L-lysine were also not activated. 
L-Leucine, however, showed activation comparable to 
Table 1 
Amino acid activation tested with the ATP- a 2 PPi 
exchange r action 
Amino aizid ATP-32 PPi exchange (cpm)* 
- aa 3180 
L-Valine 59830 
D-Valine 3650 
L-  Hydroxyisovaleric a id 3020 
L-Lactic acid 2980 
L-  Alanine 3160 
L-  Threonine 7310 
-aa, -enzyme 250 
* Twenty ~1 of the DEAE purified enzyme were used. 
L-valine suggesting a certain unspecificity of the en- 
zyme. More information about the activation of 
amino acids by the enzyme fraction derives from ex- 
periments following the fate of [~4C] ATP during the 
reaction. The enzyme incubated with [Z4C] ATP but 
without amino acids hydrolizes ATP to ADP and Pi 
as shown in fig. 2a. It is not yet clear whether this 
hydrolysis is due to the amino acid-activating enzymes 
or to a contaminant. No hydrolysis occurs without 
enzyme. In the presence of L-valine [14C] ATP is 
converted to AMP and PPi as expected from the 
ATP-PP i exchange reaction. The formation of ADP 
by the enzyme is almost completely suppressed 
(fig. 2b). In the presence of L-alanine some AMP is 
formed from ATP (fig. 2c). This is in contrast o the 
finding that L-alanine is not activated by the ATP-PP i 
exchange reaction. In the presence of L-threonine most 
of  the ATP is converted to AMP (fig. 2d). With 
phosphoenolpyruvate, pyruvate, lactate and serine very 
little or no AMP is formed. The results demonstrate 
that the enzyme fraction activates the amino acids L- 
valine, L-threonine and L-alanine, probably by form- 
hag an amino acyl-AMP complex. 
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3.3. Valinomyein synthesis nvitro 
Complete synthesis of'valinolnycin was achieved 
with the enzyme fraction purified by DEAE-cellulose 
chromatography. As expected, L- [ 14 C] val~ne is in- 
corporated into the product and is partially racemized 
to D-valine as found after acid hydrolysis and treat- 
ment with L- and D-amino acid oxidase. Very little 
L-[14C] alanine was incorporated, whereas the incor- 
poration of L-[14C] threonine is significant. That the 
product is in fact valinomycin is shown by the follow- 
ing experiments: 
1. The product cochromatographs with authentic 
valinomycin in two different systems (50% propanol 
and cyclohexane/pyridine/acetic acid)• 
2. The product contains D-valine and L-valine in 
the proportion 1 : l. 
3. The product acts as a potassium carrier through 
isolated chloroplast membranes qualitatively in the 
same way as authentic valinomycin. 
The production of valinomycin is not affected by 
pancreatic ribonuclease or puromycin, suggesting a 
synthesizing mechanism which does not involve 
messenger ribonucleic acid or ribosomes• 
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amino acids whereas valinomycin contains in addition 
the hydroxy acids D-hydroxyisovaleric a id and L-lac- 
tate, which derives in our experiments from L-valine 
and L-alanine or L-threonine, respectively. The 
mechaiaism by which the amino acids are converted 
to hydroxy acids is still unknown, especially the con- 
version of L-threonine into lactic acid is a completely 
unsolved problem. Moreover the formation of ester- 
and amide-bonds are not understood. However, the 
isolation of the valinomycin synthesizing enzymes 
allows further studies on these problems. 
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